Gene Vector Barcelona

Gene Vector Barcelona (GVB) is a Pharma CDMO granted with the MIA authorization and GMP certificates that brings to the market a unique combination of technological know-how and genuine concern for generating sustainable social, environmental, economic, and industrial value to people, as well as the capacity to onboard several key players from different fields into one unique profitable and disruptive biotechnological venture that will dramatically improve the advanced therapies for Cancer and other diseases. The GVB team understands the needs of the small- and large-scale GMP manufacturing, which, combined with the most rigorous regulations to ensure the quality, safety, and effectiveness of the product, provides innovative solutions and regulatory support to ATMPs with a tailored approach. This creates a bridge effect from the health activities and early-stage developments to clinical, marketing, and commercial-scale product delivery. GVB's services can seamlessly and efficiently cover the entire process from plasmid and lentivirus to CART, including all quality controls.